JIM
VIVO

Jensen Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Jensen Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-29,250
Closed -$558K – 116
2015
Q1 		$558K Sell
29,250
-3,570
-11% -$66K 0.01% 49
2014
Q4 		$540K Buy
+32,820
New +$563K 0.01% 57

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Jensen Investment Management's VIVO Position: Q2 2015 in Review

Jensen Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2015, closing a stake of 29,250 shares — an estimated $558K sold.

Jensen Investment Management first reported a position in VIVO in Q4 2014 and held it in 2 quarters. The position peaked at $558K in Q1 2015. 167 funds tracked by Wall St. Rank hold VIVO as of Q2 2015.

  • Jensen Investment Management reported no remaining Meridian Bioscience Inc position as of Q2 2015 after selling out during the quarter.
  • Jensen Investment Management sold 29,250 Meridian Bioscience Inc shares in Q2 2015, an estimated $558K.
  • Jensen Investment Management first reported a position in Meridian Bioscience Inc in Q4 2014 and held it in 2 quarters.
  • Jensen Investment Management's Meridian Bioscience Inc position peaked at $558K in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2015.

Based on Jensen Investment Management's 13F filing for Q2 2015, filed 29 Jul 2015.